Skip to main content
. 2018 May 24;36(22):3161–3168. doi: 10.1016/j.vaccine.2017.05.094

Table 1.

Microsphere formulations and size characterization.

Formulation BSA (% w/w) PLGA Mw (kDa) PLGA ratio Particle size (µm) 90% Threshold diametera (µm)
A 5 7–17 50:50 10.5 ± 6.8 18.5
B 3 7–17 50:50 10.6 ± 6.4 18.1
C 0.5 7–17 50:50 10.3 ± 6.2 22.1
D 0 7–17 50:50 10.5 ± 5.9 17.4
E 5 24–38 50:50 8.6 ± 6.7 21.4
F 3 24–38 50:50 11.4 ± 8.3 21.4
G 0.5 24–38 50:50 12.1 ± 8.2 23.1
H 0 24–38 50:50 11.4 ± 7.2 20.2
I 5 38–54 50:50 14.1 ± 9.4 25.4
J 3 38–54 50:50 12.0 ± 7.1 20.3
K 0.5 38–54 50:50 11.9 ± 6.8 20.6
L 0 38–54 50:50 11.9 ± 6.4 19.7
M 5 4–15 75:25 11.3 ± 7.0 19.7
N 3 4–15 75:25 12.2 ± 7.4 21.2
O 0.5 4–15 75:25 12.4 ± 7.5 21.1
P 0 4–15 75:25 11.7 ± 6.5 19.9
a

90% of particles in the formulation are smaller than this threshold.